Skip to content

Effects of a Transitional Palliative Care Model on Patients With End-stage Renal Failure

Effects of a Transitional Palliative Care Model on Patients With ESRF

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02139917
Acronym
ESRF
Enrollment
76
Registered
2014-05-16
Start date
2014-08-31
Completion date
2018-11-30
Last updated
2019-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Palliative Care, Renal Failure, End-stage

Keywords

transitional palliative care, end stage renal failure

Brief summary

Primary aim: 1. To compare the effects of customary care and an interventional Home-based Palliative Renal Program (HBPRP) for ESRF patients 2. To compare the effects of customary care and Home-based Palliative Program (HBPP) for ESRF patients Secondary aim: 3. To explore the lived experiences of patients with ESRF. Hypothesis The transitional renal palliative care model is associated with decreased in unscheduled hospital readmission, reduce length of stay as well as improved quality of life for patients with end-stage renal failure.

Detailed description

Objectives Related to the primary aim: 1. Are there differences in healthcare utilization between the ESRF patients in the customary care group and those in the HBPRP group; in the HBPRP group and HBPP group? 2. Are there differences in evaluated health outcomes (functional status, symptom intensity, and satisfaction with care) between the customary care group and the HBPRP group ; in the HBPRP group and HBPP group? 3. Are there differences in perceived health outcomes (quality of life, caregiver burden) between the customary care group and the HBPRP group; in the HBPRP group and HBPP group? Related to the secondary aim: 4. How are the lived experiences compared and contrasted between the customary care group and the HBPRP group; in the HBPRP group and HBPP group?

Interventions

BEHAVIORALTransitional community based palliative care

transitional palliative care include:- * telephone follow up for early identification of signs and symptoms * relief of signs and symptoms encountered * home visit with spiritual support

Sponsors

Hospital Authority, Hong Kong
CollaboratorOTHER_GOV
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with chronic kidney disease and diabetic mellitus with Creatinine ≥350 milli mole (uM) or those without diabetic mellitus with Creatinine ≥450 milli mole (uM) who refused renal replacement therapy (RRT); * Patient not suitable for long term renal replacement therapy (RRT) after assessment by renal team (e.g. multiple co morbidities, poor functional status and social support) * Identified as ESRF patient eligible for palliative care without prior renal replacement therapy * Ability to speak Cantonese * Living within the hospital service area * Ability to be contacted by phone

Exclusion criteria

* Discharged to nursing home or other institution * Inability to communicate * Cognitive impairment, mini mental stage examination (MMSE) \< 20 * Diagnosed with severe psychiatric disorders such as schizophrenia and bipolar disorder

Design outcomes

Primary

MeasureTime frame
Healthcare utilization composite - The dates of re-hospitalizations, length of stay, and number of other hospital services used, including clinics and emergency room visits, will be extracted from the hospital administrative systems.for 12 months

Secondary

MeasureTime frameDescription
Evaluated health outcomes composite (functional status, symptom intensity) - The functional status will be measured by the Palliative Performance Scale (PPS )(appendix 6).12 monthsThe PPS is a clinical tool commonly used in the local settings. The level of physical performance is rated on a scale of 100 (normal) to 0 (death), measured in 10 % decrement levels. The scale has been validated and the inter-rater reliability between doctors and nurses maintained at .85 with strong kappa values of .97 (Myers J, Gardiner K, Harris K et al., 2010).

Other

MeasureTime frameDescription
Perceived outcomes composite (quality of life, caregiver burden, satisfaction with care)12 monthsQuality of life will be measured by an ESRF-specific quality of life measure. The caregiver burden will be measured by the Zarit Caregiver Burden Scale (ZCBS). Satisfaction with care will be measured by the 15-item questionnaire

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026